Model-Based Drug Development To Make Better Data-Driven Decisions
Simulations Plus, Inc. (Nasdaq: SLP) is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. we offer solutions which bridge machine learning, physiologically based biopharmaceutics/pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies, and regulatory agencies worldwide.
Our reputation as thought leaders in the areas of ADMET property prediction, PBPK modeling, pharmacometrics, and quantitative systems pharmacology/toxicology is earned through the success our clients have found through their relationship with us. We have the talent and 20+ years experience to translate science into user-friendly software and provide expert consulting supporting drug discovery, clinical development research, and regulatory submissions.